1. Home
  2. CVR vs OSRH Comparison

CVR vs OSRH Comparison

Compare CVR & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chicago Rivet & Machine Co.

CVR

Chicago Rivet & Machine Co.

N/A

Current Price

$9.75

Market Cap

10.4M

Sector

Industrials

ML Signal

N/A

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.51

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVR
OSRH
Founded
1920
N/A
Country
United States
United States
Employees
N/A
21
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
11.7M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
CVR
OSRH
Price
$9.75
$0.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.9K
707.2K
Earning Date
05-08-2026
05-19-2026
Dividend Yield
1.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,890,260.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.35
N/A
52 Week Low
$8.15
$0.38
52 Week High
$15.00
$2.72

Technical Indicators

Market Signals
Indicator
CVR
OSRH
Relative Strength Index (RSI) 30.91 53.31
Support Level $8.78 $0.51
Resistance Level $14.61 $0.74
Average True Range (ATR) 0.59 0.06
MACD -0.40 0.02
Stochastic Oscillator 13.09 54.04

Price Performance

Historical Comparison
CVR
OSRH

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: